Today on The Daily Dive we have Jeff Stevens, CEO of Psyched Wellness (CSE: PSYC). Jeff sits down with our host, Cassandra Leah, to discuss the current psychedelics environment as well as some of the regulatory hurdles related to getting product to market.
Throughout, Jeff discusses the current prospects for not only Psyched Wellness, but the functional and psychedelic market as a whole. Presently, Psyched is focused on Amanita Mascaria, a functional mushroom that has psychedelic qualities, while being legal within the Canadian marketplace. Jeff’s experience with the functional fungi provides insights into bringing products to market in the natural foods space within Canada.
Within, Jeff also address the Canadian cannabis market and its parallels and differences to that of the functional and psychedelic mushroom market, from both a capital markets perspective as well as a social perspective.
FULL DISCLOSURE: Psyched Wellness is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Psyched Wellness on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
Bank Of America Lowers Gold Price Target To $2000? – The Daily Dive feat John-Mark Staude
Returning to the Daily Dive today is that of John-Mark Staude of Riverside Resources (TSXV:...